1N95 image
Deposition Date 2002-11-22
Release Date 2003-01-07
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1N95
Keywords:
Title:
Aryl Tetrahydrophyridine Inhbitors of Farnesyltranferase: Glycine, Phenylalanine and Histidine Derivatives
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.35
R-Value Work:
0.33
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase alpha subunit
Gene (Uniprot):Fnta
Chain IDs:A
Chain Length:315
Number of Molecules:1
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase beta subunit
Gene (Uniprot):Fntb
Chain IDs:B
Chain Length:402
Number of Molecules:1
Biological Source:Rattus norvegicus
Primary Citation
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives.
Bioorg.Med.Chem.Lett. 13 1359 1362 (2003)
PMID: 12657282 DOI: 10.1016/S0960-894X(03)00095-7

Abstact

Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures